老年人减停高血压药物：在不造成伤害的情况下能否降低药物负担？
Deprescribing Hypertension Medication in Older Adults: Can It Lower Drug Burden Without Causing Harm?
机构信息
Multidisciplinary Institute in Health, Federal University of Bahia, Brazil; Postgraduate Program in Pharmaceutical Services and Policies, Federal University of Bahia, Brazil.
Postgraduate Program in Pharmaceutical Services and Policies, Federal University of Bahia, Brazil; Municipal Health Department of Vitória da Conquista, Vitória da Conquista, Bahia, Brazil.
出版信息
Clin Geriatr Med. 2024 Nov;40(4):659-668. doi: 10.1016/j.cger.2024.04.012. Epub 2024 Jun 4.
Abstract
Due to the high prevalence of older individuals with multiple morbidities, polypharmacy, and exposed to unnecessary or inappropriate treatments that can cause potentially serious adverse effects, better medication management should be an objective of all health professionals. This is particularly important in older patients with hypertension. Antihypertensive deprescribing and non-pharmacological strategies have been disseminated as viable and safe alternatives for improving the quality of care for hypertension in the older population.
摘要
由于患有多种疾病、同时服用多种药物的老年人比例较高，而且他们可能会接受不必要或不适当的治疗，从而导致潜在的严重不良反应，因此更好的药物管理应该成为所有卫生专业人员的目标。这在高血压老年患者中尤为重要。抗高血压药物的停药和非药物策略已被广泛传播，作为改善老年人群高血压护理质量的可行和安全替代方案。
相似文献
1
Deprescribing Hypertension Medication in Older Adults: Can It Lower Drug Burden Without Causing Harm?老年人减停高血压药物：在不造成伤害的情况下能否降低药物负担？
Clin Geriatr Med. 2024 Nov;40(4):659-668. doi: 10.1016/j.cger.2024.04.012. Epub 2024 Jun 4.
2
The Role of Deprescribing in Older Adults with Chronic Kidney Disease.减药在老年慢性肾脏病患者中的作用
Drugs Aging. 2018 Nov;35(11):973-984. doi: 10.1007/s40266-018-0593-8.
3
Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.老年人的多药治疗、不适当处方和撤药：从性别视角看。
Lancet Healthy Longev. 2021 May;2(5):e290-e300. doi: 10.1016/S2666-7568(21)00054-4.
4
The value of deprescribing in older adults with dementia: a narrative review.老年痴呆症患者药物减量的价值：叙事性综述。
Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19.
5
Inappropriate polypharmacy management versus deprescribing: A review on their relationship.不适当的多种药物治疗管理与药物减量：对其关系的综述。
Basic Clin Pharmacol Toxicol. 2024 Jan;134(1):6-14. doi: 10.1111/bcpt.13920. Epub 2023 Jul 11.
6
Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.使用减药实践和老年人潜在不适当处方标准筛选工具，以减少老年人的伤害和可预防的药物不良事件。
J Patient Saf. 2020 Sep;16(3S Suppl 1):S23-S35. doi: 10.1097/PTS.0000000000000747.
7
Deprescribing medications in older people: a narrative review.老年人减停药物治疗：一篇叙述性综述
Drugs Today (Barc). 2018 Aug;54(8):489-498. doi: 10.1358/dot.2018.54.8.2856495.
8
Antihypertensive Deprescribing in Older Adults: a Practical Guide.老年人降压药物停药：实用指南。
Curr Hypertens Rep. 2022 Nov;24(11):571-580. doi: 10.1007/s11906-022-01215-3. Epub 2022 Jul 26.
9
Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.优化患有多种疾病和多种药物治疗的老年患者的药物治疗和减药策略：EuGMS 药理学工作组关于立场文件的建议。
Eur Geriatr Med. 2023 Dec;14(6):1195-1209. doi: 10.1007/s41999-023-00872-0. Epub 2023 Oct 9.
10
Thoughtful Prescribing and Deprescribing.审慎处方与撤方。
Med Clin North Am. 2020 Sep;104(5):751-765. doi: 10.1016/j.mcna.2020.06.001.
引用本文的文献
1
Prescription architecture for better blood pressure control: smart strategies to manage polypharmacy.改善血压控制的处方架构：管理联合用药的明智策略。
Hypertens Res. 2025 Jun 5. doi: 10.1038/s41440-025-02250-8.
本文引用的文献
1
Optimal Blood Pressure Targets with Age.最佳血压目标与年龄相关。
Clin Geriatr Med. 2024 Nov;40(4):585-595. doi: 10.1016/j.cger.2024.04.002. Epub 2024 May 10.
2
Long-term Monitoring of Blood Pressure in Older Adults: A Focus on Self-Measured Blood Pressure Monitoring.老年人的血压长期监测：以自我测量血压监测为重点。
Clin Geriatr Med. 2024 Nov;40(4):573-583. doi: 10.1016/j.cger.2024.04.009. Epub 2024 May 23.
3
Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.在常规实践中识别停用降压药物患者的策略：证据综述。
Curr Hypertens Rep. 2024 May;26(5):225-236. doi: 10.1007/s11906-024-01293-5. Epub 2024 Feb 2.
4
Tools and guidelines to assess the appropriateness of medication and aid deprescribing: An umbrella review.评估药物适宜性和辅助减药的工具和指南：伞式综述。
Br J Clin Pharmacol. 2024 Jan;90(1):12-106. doi: 10.1111/bcp.15906. Epub 2023 Oct 24.
5
Screening for orthostatic hypotension in the geriatric population in a real-world primary care setting reduces prescribed antihypertensive medications.在真实的初级保健环境中对老年人群进行体位性低血压筛查可减少处方降压药物的使用。
Blood Press Monit. 2023 Dec 1;28(6):338-342. doi: 10.1097/MBP.0000000000000673. Epub 2023 Aug 24.
6
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER).一种减少多种用药及其负面健康影响的模型的理论基础：引入团队方法评估和减少多种用药（TAPER）。
Drugs Aging. 2023 Sep;40(9):857-868. doi: 10.1007/s40266-023-01055-z. Epub 2023 Aug 21.
7
Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment.降压药物停药偏好研究：临床医生、护理人员和痴呆症患者的离散选择实验。
Age Ageing. 2023 Aug 1;52(8). doi: 10.1093/ageing/afad153.
8
Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?非常高龄衰弱人群的降压治疗：是否需要范式转变？
J Hypertens. 2023 Oct 1;41(10):1502-1510. doi: 10.1097/HJH.0000000000003495. Epub 2023 Jul 5.
9
Optimizing Hypertension Treatment in Older Patients Through Home Blood Pressure Monitoring by Pharmacists in Primary Care: The MINOR Clinical Trial.通过初级保健药师进行家庭血压监测优化老年高血压患者的治疗：MINOR 临床试验。
Clin Ther. 2023 Oct;45(10):941-946. doi: 10.1016/j.clinthera.2023.06.007. Epub 2023 Jun 24.
10
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3.老年人潜在不适当处方的 STOPP/START 标准：第 3 版。
Eur Geriatr Med. 2023 Aug;14(4):625-632. doi: 10.1007/s41999-023-00777-y. Epub 2023 May 31.
Zotero 插件